文献速递青光眼

Schlemm管活体成像及对选择性激光小梁成形术反应

In Vivo Imaging of the Schlemm's Canal and the Response to Selective Laser Trabeculoplasty.
PubMed 文献 · Am J Ophthalmol · 2021-07-18

前瞻性队列研究纳入无房角发育异常的青少年起病开角型青光眼患者,用前节OCT评估房角发育异常(ADoA)预测SLT疗效。57.1%患眼6个月眼压降幅≥20%,平均降7.6±1.8 mmHg(29.6%);OCT可见Schlemm管者成功率显著更高。

要点

  • ASOCT识别Schlemm管是SLT成功的强预测因素。
  • 存在高反射膜者SLT全部失败。
  • Schlemm管见于>50%扫描切面者全部成功。

核心结论

  • ASOCT上Schlemm管的存在是JOAG患眼SLT后眼压成功降低的强预测因素。

研究设计与样本

  • 前瞻性临床队列研究,纳入房角镜下无房角发育异常的青少年起病开角型青光眼患者。

主要发现

  • 57.1%患眼(20/35)在6个月时眼压较SLT前降低>20%,平均降低7.6±1.8 mmHg(29.6%)。
  • 3名观察者一致时,成功组90%患眼(18/20)识别Schlemm管,失败组26.6%患眼(4/15),P < .001。
  • 存在高反射膜的患眼(5/5)全部失败,P < .001。
  • Schlemm管见于>50% ASOCT B扫描(>25/50扫描/眼)的患眼(19/19)全部成功,P < .001。
  • 偏倚减少回归分析中,任意连续2个扫描切面识别Schlemm管使6个月成功几率增加8.3倍,>50%扫描切面识别则增加21.4倍。

关键数值与推荐

  • SLT成功定义为6个月随访时眼压较激光前降低≥20%,且未追加降眼压药物或手术。
  • 6个月期内仅允许1次重复SLT用于定义SLT成功。
  • ADoA定义为ASOCT上Schlemm管缺失和/或小梁网上方存在高反射膜。

临床怎么用

  • 对JOAG患者行SLT前可用ASOCT评估Schlemm管及高反射膜,以预判疗效。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the presence of angle dysgenesis on ASOCT (anterior segment optical coherence tomography) (ADoA) as a predictive factor in determining outcomes of selective laser trabeculoplasty (SLT). DESIGN: A prospective clinical cohort study. SUBJECTS: Patients with juvenile-onset open-angle glaucoma (JOAG) without angle dysgenesis on gonioscopy. METHOD: JOAG patients with uncontrolled intraocular pressure (IOP), who were to undergo SLT, were evaluated for the presence or absence of ADoA, which was defined as the absence of Schlemm's canal (SC) and/or presence of a hyperreflective membrane (HM) over the trabecular meshwork, as identified on ASOCT before the SLT procedure. Furthermore, the number of ASOCT B-scans in which SC was identified as present, were then quantified. Success of SLT was defined as a reduction of IOP by 20% or more from pre-laser value at 6-month follow-up without any further IOP-lowering medication or surgery. Only 1 repeat SLT was admissible for defining SLT success over the 6-month period. A successful reduction in IOP at 6-month follow-up was correlated with the extent of ADoA. RESULTS: In comparison to pre-SLT IOP, 57.1% eyes (20/35) showed more than 20% reduction in IOP at 6 months with a mean reduction of 7.6 ± 1.8 mm Hg (29.6%). When all 3 observers agreed, SC was identified in 90% eyes (18/20) with success vs 26.6% eyes (4/15) with failure (P < .001). All eyes (5/5) with presence of HM showed failure (P < .001). All eyes (19/19) in which SC was present in >50% ASOCT B scans (>25/50 scans/eye) showed success (P < .001). On a bias-reduced regression analysis, the identification of SC on any 2 consecutive scans increased the chances of success at 6 months by 8.3 times, whereas the identification of SC in >50% of ASOCT scans was associated with a 21.4 times greater chance of success. CONCLUSIONS: The presence of SC on ASOCT is a strong predictor for successful IOP reduction after SLT in JOAG eyes.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Varshney T, Azmira K, Gupta S, et al. In Vivo Imaging of the Schlemm's Canal and the Response to Selective Laser Trabeculoplasty. Am J Ophthalmol. 2021. PMID: 34289336. doi:10.1016/j.ajo.2021.07.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。